USF Well being is recruiting youngsters aged six months to 11 years in Moderna vaccine examine

TAMPA, Fla. (WFLA) – As kids go back to school during the Florida variant’s COVID-19 wave of Delta Variation, many parents want to know when their children under the age of 12 might be able to be vaccinated.

The USF Health Morsani College of Medicine announced on Wednesday that it had been selected to participate in the clinical trial testing the advanced Covid-19 vaccine for children aged 6 months to under 11 years.

Spike in pediatric COVID cases worries doctors at Johns Hopkins All Children’s Hospital

“USF Health is excited to participate in this national clinical trial to determine the safety and effectiveness of Moderna vaccines in children and younger populations,” said Charles Lockwood, MD, senior vice president of USF Health and dean of USF Health Morsani College of Medicine. “Widespread vaccination is the best defense against COVID-19, and this rigorous scientific study can go a long way in improving access to vaccines among this younger population.”

Space is limited in this local study, where three out of four children are given two doses of the Moderna vaccine four weeks apart.

“I just want as many guns as possible,” said Dr. Jennifer Jain from Tampa.

Her two daughters will be two and four years old in October, so they still haven’t been vaccinated.

“I literally jumped for joy when I heard about this,” said Dr. Jain on USF Health’s participation in the study. “I had contact with the people in Jacksonville because of their Moderna study.”

Florida County overwhelmed by COVID-19 911 calls; Officials ask residents to use the service sparingly

Before speaking to 8 On Your Side, she had already contacted USF Health.

“I am very eager to have my children vaccinated,” Jain said. “COVID is a frightening disease. As you know, the numbers are going through the roof and a lot of children are getting sick, and yes it is true. Most children are fine, but not all. “

Dr. Carina Rodriguez, professor and director of the Department of Pediatric Infectious Diseases in the Department of Pediatrics at USF Health Morsani College of Medicine, will be the principal investigator of the USF Health study.

“This research study can help provide critical information about the safety, reactogenicity and immune responses seen with the vaccine in children and ultimately allow the vaccine to be approved for use in children,” said Dr. Rodriguez. “A vaccine that prevents COVID-19 disease in children would be a critical public health tool to contain the pandemic. We are committed to contributing to the cutting edge science that is working to provide a safe and effective solution for our younger patients who are also vulnerable to this health threat. “

Dr. Rodriguez told 8 On Your Side that demand is high as many families have already expressed an interest in enrolling their children.

“We want to make sure it is very representative of each individual ethnicity and race,” she said of enrolling a different group of children.

After Pfizer submitted its vaccine safety data to the FDA for review by the end of September, children under the age of 12 could start using gun syringes this fall.

Biden DeSantis battle for masked students comes to St. Pete

“I heard that this might not be for the little ones,” said Jain. “It could be 5 to 11, so I’m considering enrolling my children in this study. But as soon as my children get the vaccine, they are there. “

Rodriguez stated that the dosage levels for toddlers will be lower than for older children in the Moderna study.

She wouldn’t say exactly how many local children will be participating, but Moderna would like to enroll 12,000 in the US and Canada for the second phase of the study called the KidCOVE Study.

Participating children will be monitored for 12 months after vaccination.

Eligibility criteria

Study volunteers must be:

  • Between 6 months and 11 years
  • In good health or with stable chronic diseases

Study volunteers are not allowed to:

  • have received a vaccine against COVID-19 that is being investigated or approved
  • Are you currently taking any investigated or approved treatments for COVID-19
  • Have tested positive for COVID-19 or have had contact with someone diagnosed with COVID-19 within 2 weeks of being given the vaccine
  • participated in a clinical study in the last month

Enrollment for the USF Health Moderna KidCOVE trial will begin in the coming days via email ([email protected]) or phone / SMS (813-853-1149).

Comments are closed.